Sudan (the)

in page functions
[French]
Total population (2014) 38,764,090
Birth cohort (2014) 1,287,352
Surviving Infants (surviving to 1 year per year, 2014) 1,218,107
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 49/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 73/1000
World Bank Index, IDA (2012) 2.44
Gross Nation Income (per capita US$, 2012) 1,450
Co-financing status (2013) Intermediate
No. of districts/territories (2012) 162

GAVI support for Sudan

Type of support

Approvals

2001-2020 (US$)
(31 May 2014)

Commitments

2001-2020 (US$)
(31 May 2014)

Disbursements

2000-2014 (US$)
(31 May 2014)

% Disbursed

(31 May 2014)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Health system strengthening (HSS) $16,153,500 $16,153,500 $16,153,500 100%
Health system strengthening (HSS 2) $14,249,652 $33,231,766
HepB mono (NVS) $3,027,132 $3,027,132 $3,027,132 100%
Immunisation services support (ISS) $11,229,380 $11,229,380 $10,598,300 94%
Injection safety support (INS) $1,321,257 $1,321,257 $1,321,257 100%
Meningitis A - campaign (NVS) $18,334,472 $18,334,472 $19,100,597 104%
Meningitis A - operational costs (OPC) $16,135,366 $16,135,366 $16,135,366 100%
Penta (NVS) $75,907,448 $75,907,448 $74,648,198 98%
Pneumo (NVS) $39,227,000 $39,227,000 $33,330,258 85%
Rotavirus (NVS) $22,444,754 $22,444,754 $24,004,258 107%
Vaccine Introduction Grant (VIG) $1,586,500 $1,586,500 $1,586,500 100%
Yellow Fever - campaign (NVS) $17,261,500 $39,453,000
YF - Operational costs (OPC) $5,824,391 $15,193,782
Total $242,702,352 $293,245,357 $199,905,365

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sudan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
92%

**
DTP3 - Official country estimates (2012) 92%
M:F sex ratio at birth (2014) 1.04
Household survey: DTP3 coverage for male (2006) 53.70%
Household survey: DTP3 coverage for female (2006) 55.90%
Household survey: Last DTP3 survey (2010) 59%
% districts achieving > 80% DTP3 coverage (2012) 82%
% districts achieving < 50% DTP3 coverage (2012) 2%
MCV WHO/UNICEF estimates (2012) 85%
Polio WHO/UNICEF estimates (2012) 92%

Breakdown of support

Non-vaccine support Vaccine support
23% 77%
$45,794,923 $154,110,441

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sudan

06 May 2014

Default library results

GAVI Alliance welcomes availability of Indian pentavalent vaccine

The GAVI Alliance welcomes the announcement that an additional pentavalent vaccine has received prequalification by the World Health Organization (WHO).

30 October 2013

MTR group photo final PR

GAVI Alliance partners reaching more children than ever before with accelerated access to vital vaccines

Mid-Term Review meeting highlights immunisation successes and challenges.

30 October 2013

Seth Berkley speaks at MTR

A-Z of GAVI successes and challenges - Seth Berkley’s mid-term review

Dr Seth Berkley, GAVI CEO started the Mid-Term Review with an all-encompassing presentation highlighting the Alliance’s progress in delivering against its 2011-15 strategic goals. Read the A-Z of the key themes in the presentation.

close icon

modal window here